Aktienanalyse zu Guardian Pharmacy Services Inc (GRDN)GRDNGuardian Pharmacy Services Inc

Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. It offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. It organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. It offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations. It operates in the Consumer Non-Cyclicals sector.

Guardian Pharmacy Services Inc is currently a hold. The stock is trading at $39.47, which is below the analyst consensus target of $49.81, indicating potential upside. However, the RSI is at 32.151, suggesting it is oversold, and the stock has seen a 5-day decline of 4.38%. The main risk is the recent performance trend, with a year-to-date change of +33.66% but a 20-day change of -12.27%, indicating volatility.